Pelviva, a novel disposable ‘tampon-like’ electro-stimulation device for the treatment of incontinence, was one of MIMT’s first developments.
This innovative technology is anticipated to become a mainstream approach to the treatment of bladder-leakage, accessible to all women, and is expected to improve quality of life for millions of sufferers.
The device was developed in partnership with industry collaborator Femeda, an SME based in North-
East England, and the licence agreement was facilitated by UMIP and TrusTECH. It has been granted world-wide patents, and has attracted over £8 million in venture capital as well as more than £200,000 in industry-supported research funding.
Pelviva won the Bionow Healthcare Project of the Year in 2010, is now CE marked will be launched in 2014.